Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2026International Journal of Molecular SciencesOpen Access

Peptidoglycan Suppresses Melanoma Growth in a Murine Model with Local Immune Activation

View Full Paper
Ask AI
Bookmark
Share

Authors

AIAyaka IchikawaMie UniversityTNTakehisa NakanishiMie UniversityMNMai NishimuraMie University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ichikawa et al. (2026) studied this question.

synapsesocial.com/papers/6ab9b5c47822ec8fc3d90bf3https://doi.org/10.3390/ijms27198584
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain2015 · 184 citations
  2. 2Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells2011 · 1,195 citations
  3. 3Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation2014 · 5,458 citations
  4. 4Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group2008 · 751 citations
  5. 5Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production2007 · 34 citations